Delivery Order SPE2DB20D7066-SPE2DB25FC2VN

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,506.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FYAH3) for the supply of 4,568,055,092 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,362.88 firm-fixed-price delivery order is for the supply of 4,568,192,443 units of the prescription medication Dextroamphetamine-Amphetamine 10 mg capsules. The contract has a period of performance extending through May 9, 2025 and was awarded on May 8, 2025. This delivery order is part of...
This federal contract award, valued at $2,127.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,143,281 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of May 6, 2025. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,439.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,956,585 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules, in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2025. This award is not a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,776,079 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The $1,126.92 firm fixed-price contract has a completion date of December 23, 2024. It is not designated as a set-aside contract. This award appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,694,053 units of dextroamphetamine-amphetamine 10 mg capsules in lots of 100. The contract has a ceiling value of $1,070.34 and a period of performance through March 26, 2025. It is a delivery order contract with a firm fixed price pricing type. The award is not associated with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.89, is a Firm Fixed Price Delivery Order to provide 4,567,886,472 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. The award has an ultimate completion date of April 14, 2025. This contract is not associated with a set-aside designation. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,126.56 firm fixed-price delivery order is for the supply of 4,568,145,994 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract has a performance period extending through May 6, 2025 and was awarded on May 5, 2025. This award is associated with Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,449.40 firm fixed-price delivery order is for the supply of 4,562,967,887 units of Dextroamphetamine ER 10 mg capsules. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $4,670.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,119,755 units of the prescription medication dextroamphetamine-amphetamine 5 mg tablets. The contract has a firm-fixed price and an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2VN
    Delivery Order

This federal contract award, valued at $5,457.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply 4,567,771,288 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2025. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs. As a major supplier of medical and pharmaceutical products to federal agencies, Amerisourcebergen leverages its position to fulfill diverse medication and medical supply requirements for the U.S. government, particularly for the Defense Health Agency, U.S. Coast Guard, and other military and veteran healthcare systems.

Generated 7/18/25, 10:13 AM